2 insiders reported 4 Form 4 transactions for Telix Pharmaceuticals Ltd (TLX) over the past 18 months (most recent 2026-09-14). Recent activity: Smith Darren Charlton (Group Chief Financial Officer) Buy 2,071 shares, Behrenbruch Christian (MD & Group CEO) Buy 34,500 shares, Behrenbruch Christian (MD & Group CEO) Buy 33,435 shares, Smith Darren Charlton (Group Chief Financial Officer) Buy 1,111 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | Smith Darren Charlton | Group Chief Financial Officer | Buy | 2,071 | $19,998 |
| 2026-05-06 | Behrenbruch Christian | MD & Group CEO | Buy | 34,500 | $499,560 |
| 2026-05-06 | Behrenbruch Christian | MD & Group CEO | Buy | 33,435 | $497,178 |
| 2026-04-01 | Smith Darren Charlton | Group Chief Financial Officer | Buy | 1,111 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14